APA

Willard M. D., Lajiness M. E., Wulur I. H., Feng B., Swearingen M. L., Uhlik M. T., Kinzler K. W., Velculescu V. E., Sjöblom T., Markowitz S. D., Powell S. M., Vogelstein B. & Barber T. D. (20121030). Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes. : Molecular cancer research : MCR.

Chicago

Willard Melinda D, Lajiness Mary E, Wulur Isabella H, Feng Bo, Swearingen Michelle L, Uhlik Mark T, Kinzler Kenneth W, Velculescu Victor E, Sjöblom Tobias, Markowitz Sanford D, Powell Steven M, Vogelstein Bert and Barber Thomas D. 20121030. Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes. : Molecular cancer research : MCR.

Harvard

Willard M. D., Lajiness M. E., Wulur I. H., Feng B., Swearingen M. L., Uhlik M. T., Kinzler K. W., Velculescu V. E., Sjöblom T., Markowitz S. D., Powell S. M., Vogelstein B. and Barber T. D. (20121030). Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes. : Molecular cancer research : MCR.

MLA

Willard Melinda D, Lajiness Mary E, Wulur Isabella H, Feng Bo, Swearingen Michelle L, Uhlik Mark T, Kinzler Kenneth W, Velculescu Victor E, Sjöblom Tobias, Markowitz Sanford D, Powell Steven M, Vogelstein Bert and Barber Thomas D. Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes. : Molecular cancer research : MCR. 20121030.